European Commission proposes a change to intellectual property rules to let generic drugmakers enter non-EU markets faster. Patent holders are not happy
A European research team is developing a photonic-ultrasound-based detector that will save water companies from closure in the wake of tough new drinking-water regulations, soon to be implemented by the WHO, providing the quickest ever safety diagnosis for deadly bacteria.
In a paper setting out its negotiating terms, the government calls for a far reaching-science and innovation pact and says it will respect the remit of the European Court of Justice
The era of prescription digital health has dawned with approval of an app assessed to the same standard of clinical evidence as a conventional drug. Now pharma companies and digital therapy pioneers are forging development and marketing deals, while EU regulators and payers flounder
IMI is celebrating its 10th anniversary with a high-level event in Brussels on 27 June. Join us to meet IMI projects and explore their successes and the impact they are having on drug development.
The seal of excellence is as much a signifier of the EU’s R&D funding shortfall as it is of Europe’s high quality science. Now, the EU wants money from the cohesion programme to fill the funding gap and translate research to market
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.